Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms

Lipoxygenases (ALOX-isoforms) are lipid peroxidizing enzymes, which have been implicated in cell differentiation and maturation but also in the biosynthesis of lipid mediators playing important roles in the pathogenesis of inflammatory, hyperproliferative and neurological diseases. In mammals these...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kumar Reddy Kakularam, Felix Karst, Aparoy Polamarasetty, Igor Ivanov, Dagmar Heydeck, Hartmut Kuhn
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/ceedff28c8c34ca48c9278f1abd92056
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ceedff28c8c34ca48c9278f1abd92056
record_format dspace
spelling oai:doaj.org-article:ceedff28c8c34ca48c9278f1abd920562021-11-20T04:55:52ZParalog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms0753-332210.1016/j.biopha.2021.112434https://doaj.org/article/ceedff28c8c34ca48c9278f1abd920562022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221012208https://doaj.org/toc/0753-3322Lipoxygenases (ALOX-isoforms) are lipid peroxidizing enzymes, which have been implicated in cell differentiation and maturation but also in the biosynthesis of lipid mediators playing important roles in the pathogenesis of inflammatory, hyperproliferative and neurological diseases. In mammals these enzymes are widely distributed and the human genome involves six functional genes encoding for six distinct human ALOX paralogs. In mice, there is an orthologous enzyme for each human ALOX paralog but the catalytic properties of human and mouse ALOX orthologs show remarkable differences. ALOX inhibitors are frequently employed for deciphering the biological role of these enzymes in mouse models of human diseases but owing to the functional differences between mouse and human ALOX orthologs the uncritical use of such inhibitors is sometimes misleading. In this study we evaluated the paralog- and ortholog-specificity of 13 frequently employed ALOX-inhibitors against four recombinant human and mouse ALOX paralogs (ALOX15, ALOX15B, ALOX12, ALOX5) under different experimental conditions. Our results indicated that except for zileuton, which exhibits a remarkable paralog-specificity for mouse and human ALOX5, no other inhibitor was strictly paralog specific but some compounds exhibit an interesting ortholog-specificity. Because of the variable isoform specificities of the currently available ALOX inhibitors care must be taken when the biological effects of these compounds observed in complex in vitro and in vivo systems are interpreted.Kumar Reddy KakularamFelix KarstAparoy PolamarasettyIgor IvanovDagmar HeydeckHartmut KuhnElsevierarticleEicosanoidsLipoxygenaseInhibitorsLeukotrienesResolvinsTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112434- (2022)
institution DOAJ
collection DOAJ
language EN
topic Eicosanoids
Lipoxygenase
Inhibitors
Leukotrienes
Resolvins
Therapeutics. Pharmacology
RM1-950
spellingShingle Eicosanoids
Lipoxygenase
Inhibitors
Leukotrienes
Resolvins
Therapeutics. Pharmacology
RM1-950
Kumar Reddy Kakularam
Felix Karst
Aparoy Polamarasetty
Igor Ivanov
Dagmar Heydeck
Hartmut Kuhn
Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
description Lipoxygenases (ALOX-isoforms) are lipid peroxidizing enzymes, which have been implicated in cell differentiation and maturation but also in the biosynthesis of lipid mediators playing important roles in the pathogenesis of inflammatory, hyperproliferative and neurological diseases. In mammals these enzymes are widely distributed and the human genome involves six functional genes encoding for six distinct human ALOX paralogs. In mice, there is an orthologous enzyme for each human ALOX paralog but the catalytic properties of human and mouse ALOX orthologs show remarkable differences. ALOX inhibitors are frequently employed for deciphering the biological role of these enzymes in mouse models of human diseases but owing to the functional differences between mouse and human ALOX orthologs the uncritical use of such inhibitors is sometimes misleading. In this study we evaluated the paralog- and ortholog-specificity of 13 frequently employed ALOX-inhibitors against four recombinant human and mouse ALOX paralogs (ALOX15, ALOX15B, ALOX12, ALOX5) under different experimental conditions. Our results indicated that except for zileuton, which exhibits a remarkable paralog-specificity for mouse and human ALOX5, no other inhibitor was strictly paralog specific but some compounds exhibit an interesting ortholog-specificity. Because of the variable isoform specificities of the currently available ALOX inhibitors care must be taken when the biological effects of these compounds observed in complex in vitro and in vivo systems are interpreted.
format article
author Kumar Reddy Kakularam
Felix Karst
Aparoy Polamarasetty
Igor Ivanov
Dagmar Heydeck
Hartmut Kuhn
author_facet Kumar Reddy Kakularam
Felix Karst
Aparoy Polamarasetty
Igor Ivanov
Dagmar Heydeck
Hartmut Kuhn
author_sort Kumar Reddy Kakularam
title Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
title_short Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
title_full Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
title_fullStr Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
title_full_unstemmed Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
title_sort paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms
publisher Elsevier
publishDate 2022
url https://doaj.org/article/ceedff28c8c34ca48c9278f1abd92056
work_keys_str_mv AT kumarreddykakularam paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
AT felixkarst paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
AT aparoypolamarasetty paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
AT igorivanov paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
AT dagmarheydeck paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
AT hartmutkuhn paralogandorthologspecificityofinhibitorsofhumanandmouselipoxygenaseisoforms
_version_ 1718419741576527872